09:45 AM EST - TSO3 Inc. : announced that the Company has signed its first commercial agreement with Getinge Infection Control in support of the launch of the STERIZONE® VP4 Sterilization System. The non-exclusive agreement covers multiple markets in which Getinge has significant market share, including North America and other selected markets. Efforts to launch the product will begin immediately. TSO3 Inc.
shares T.TOS are trading up $0.22 at $1.39.
